Rainmed Medical Limited (HKG:2297)
0.1640
0.00 (0.00%)
May 19, 2025, 3:27 PM HKT
Rainmed Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 54.61 | 134.09 | 91.12 | 559.14 |
Short-Term Investments | 11.09 | 65.55 | 355.2 | - |
Trading Asset Securities | 139.85 | 135.65 | 132.65 | - |
Cash & Short-Term Investments | 205.55 | 335.28 | 578.96 | 559.14 |
Cash Growth | -38.69% | -42.09% | 3.55% | - |
Accounts Receivable | 2.09 | 3.69 | 3.68 | - |
Other Receivables | 16.4 | 6.66 | 6.39 | 0.38 |
Receivables | 18.49 | 10.35 | 10.07 | 0.38 |
Inventory | 11.05 | 9.79 | 7.61 | 9.91 |
Other Current Assets | 2.83 | 13.8 | 6.8 | 6.22 |
Total Current Assets | 237.91 | 369.22 | 603.43 | 575.65 |
Property, Plant & Equipment | 150.17 | 117.65 | 38.74 | 43.2 |
Goodwill | 6.81 | 12.59 | - | - |
Other Intangible Assets | 5.08 | 6.37 | 0.89 | 0.24 |
Long-Term Deferred Tax Assets | 24.63 | 24.63 | 24.62 | 19.16 |
Long-Term Deferred Charges | 38.11 | 35.18 | 12.21 | - |
Other Long-Term Assets | 0.36 | 7.67 | 10.44 | 1.94 |
Total Assets | 463.06 | 573.31 | 690.33 | 640.19 |
Accounts Payable | 7.4 | 4.56 | 4.36 | 1.83 |
Accrued Expenses | 13.55 | 24.47 | 34.87 | 15.47 |
Short-Term Debt | - | - | 18 | - |
Current Portion of Long-Term Debt | 18.69 | 3.89 | - | - |
Current Portion of Leases | 2.32 | 4.06 | 7.4 | 7.82 |
Current Income Taxes Payable | 0.03 | 0.01 | - | 3.53 |
Current Unearned Revenue | 6.36 | 3.98 | 3.49 | 6.73 |
Other Current Liabilities | - | - | - | 8.69 |
Total Current Liabilities | 48.34 | 40.98 | 68.12 | 44.07 |
Long-Term Debt | 3.89 | 11.68 | - | 1,362 |
Long-Term Leases | 0.69 | 0.37 | 3.58 | 8.86 |
Long-Term Deferred Tax Liabilities | 0.23 | 0.27 | - | - |
Total Liabilities | 53.15 | 53.3 | 71.69 | 1,415 |
Common Stock | 0.1 | 0.1 | 0.1 | 0 |
Additional Paid-In Capital | 2,787 | 2,787 | 2,787 | - |
Retained Earnings | -2,449 | -2,335 | -2,220 | -873.59 |
Comprehensive Income & Other | 68.95 | 63.51 | 51.26 | 86.11 |
Total Common Equity | 407 | 515.05 | 618.64 | -787.48 |
Minority Interest | 2.92 | 4.96 | - | - |
Shareholders' Equity | 409.91 | 520.01 | 618.64 | -774.48 |
Total Liabilities & Equity | 463.06 | 573.31 | 690.33 | 640.19 |
Total Debt | 25.58 | 20 | 28.98 | 1,378 |
Net Cash (Debt) | 179.97 | 315.28 | 549.98 | -819.29 |
Net Cash Growth | -42.92% | -42.67% | - | - |
Net Cash Per Share | 0.15 | 0.27 | 0.61 | -1.27 |
Filing Date Shares Outstanding | 1,168 | 1,168 | 1,168 | 644.52 |
Total Common Shares Outstanding | 1,168 | 1,168 | 1,168 | 644.52 |
Working Capital | 189.57 | 328.23 | 535.31 | 531.58 |
Book Value Per Share | 0.35 | 0.44 | 0.53 | -1.22 |
Tangible Book Value | 395.11 | 496.09 | 617.75 | -787.73 |
Tangible Book Value Per Share | 0.34 | 0.42 | 0.53 | -1.22 |
Machinery | 20.44 | 20.46 | 11.33 | 6.58 |
Construction In Progress | 124.31 | 81.56 | 2.14 | 4.78 |
Leasehold Improvements | 38.45 | 38.34 | 35.05 | 25.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.